Lev's disease

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Lev's disease
Synonyms Lenegre-Lev syndrome
Pronounce N/A
Specialty N/A
Symptoms Heart block, bradycardia, syncope
Complications Sudden cardiac death
Onset Typically in older adults
Duration Chronic
Types N/A
Causes Fibrosis and calcification of the cardiac conduction system
Risks Aging, hypertension, diabetes mellitus
Diagnosis Electrocardiogram (ECG), Holter monitor, Electrophysiology study
Differential diagnosis Lenegre's disease, Ischemic heart disease, Dilated cardiomyopathy
Prevention N/A
Treatment Pacemaker implantation
Medication N/A
Prognosis Variable, depends on timely treatment
Frequency Rare
Deaths N/A


Lev's disease is a rare medical condition characterized by the degeneration of the electrical conduction system of the heart. This condition is named after the Russian pathologist Maurice Lev, who first described it in 1950.

Symptoms[edit]

The symptoms of Lev's disease can vary greatly from person to person. Some individuals may not experience any symptoms, while others may experience symptoms such as:

Causes[edit]

Lev's disease is caused by the degeneration of the electrical conduction system of the heart. This degeneration can be due to aging, or it can be caused by other factors such as:

Diagnosis[edit]

Diagnosis of Lev's disease typically involves a thorough medical history and physical examination, as well as various tests such as:

Treatment[edit]

Treatment for Lev's disease typically involves managing the symptoms and preventing complications. This can include:

Prognosis[edit]

The prognosis for individuals with Lev's disease can vary greatly depending on the severity of the condition and the individual's overall health. However, with appropriate treatment and management, many individuals with Lev's disease can lead normal, healthy lives.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.